TABLE 1.
Mics of antibiotics and compounds.
| Category | Antibiotics | MIC (μ g/mL)/antimicrobial susceptibility | |||||
| Ec15103 | Ec600 | EPI300 | Ec15103 -Ec600 |
Ec15103- EPI300-1 |
Ec15103- EPI300-2 |
||
| β-Lactams | Ampicillin | ≥32R | ≤8S | ≤8S | ≥32R | ≥32R | ≥32R |
| Ampicillin/sulbactam | =32/16R | ≤2/1S | ≤2/1S | =32/16R | =32/16R | =32/16R | |
| Cefazolin | ≥8R | ≤2S | ≤2S | ≥8R | ≤2S | ≥8R | |
| Cefuroxime | ≥32R | ≤8S | ≤8S | ≥32R | ≤8S | ≥32R | |
| Ceftriaxone | ≥64R | ≤1S | ≤1S | ≥64R | ≤1S | ≥64R | |
| Cefotaxime | ≥8R | ≤4S | ≤4S | ≥8R | ≤4S | ≥8R | |
| Cefotaxime/clavulanic acid | ≤1/4S | ≤1/4S | ≤1/4S | ≤1/4S | ≤1/4S | ≤1/4S | |
| Ceftazidime | =16R | ≤4S | ≤4S | ≤4S | ≤4S | ≤4S | |
| Ceftazidime/clavulanic acid | ≤1/4S | ≤1/4S | ≤1/4S | ≤1/4S | ≤1/4S | ≤1/4S | |
| Cefoxitin | ≤8S | ≤8S | ≤8S | ≤8S | ≤8S | ≤8S | |
| Cefepime | ≥32R | ≤2S | ≤2S | ≤2S | ≤2S | ≤2S | |
| Piperacillin/tazobactam | ≤4/4S | ≤4/4S | ≤4/4S | ≤4/4S | ≤4/4S | ≤4/4S | |
| Ticarcillin/clavulanic acid | =64/2I | ≤4/2S | ≤4/2S | =64/2I | =64/2I | =64/2I | |
| Cefoperazone/sulbactam | =16/8S | ≤2/1S | ≤2/1S | =16/8S | ≤2/1S | =16/8S | |
| Carbapenems | Meropenem | ≤1S | ≤1S | ≤1S | ≤1S | ≤1S | ≤1S |
| Imipenem | ≤1S | ≤1S | ≤1S | ≤1S | ≤1S | ≤1S | |
| Aminoglycosides | Gentamicin | ≥16R | ≤1S | ≤1S | ≤1S | ≥16R | ≥16R |
| Amikacin | ≤4S | ≤4S | ≤4S | ≤4S | ≤4S | ≤4S | |
| Fluoroquinolones | Ciprofloxacin | ≥4R | ≤0.06S | ≤0.06S | ≤0.06S | ≤0.06S | ≤0.06S |
| Levofloxacin | =4I | ≤0.12S | ≤0.12S | ≤0.12S | ≤0.12S | ≤0.12S | |
| Others | Polymyxin B | ≤2S | ≤2S | ≤2S | ≤2S | ≤2S | ≤2S |
| Co-trimoxazole | ≥8/152R | ≤0.5/9.5S | =4/76R | ≤0.5/9.5S | ≥8/152R | ≥8/152R | |
| Nitrofurantoin | ≤16S | ≤16S | ≤16S | ≤16S | ≤16S | ≤16S | |
| Minocycline | ≤4S | ≤4S | ≤4S | ≤4S | ≤4S | ≤4S | |
| Chloromycetin | ≤8S | ≤8S | ≤8S | ≤8S | ≤8S | ≤8S | |
S: susceptible; I: intermediate; R: resistant.